Compare Antengene Corp. Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 6.39%
- The company is Net-Debt Free
2
Flat results in Dec 25
3
Risky -
4
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.56%
0%
0.56%
6 Months
-8.67%
0%
-8.67%
1 Year
-44.41%
0%
-44.41%
2 Years
528.07%
0%
528.07%
3 Years
231.48%
0%
231.48%
4 Years
9.82%
0%
9.82%
5 Years
-69.14%
0%
-69.14%
Antengene Corp. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
-7.59
Debt to EBITDA (avg)
3.38
Net Debt to Equity (avg)
-0.77
Sales to Capital Employed (avg)
0.69
Tax Ratio
16.11%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
6.39%
Valuation key factors
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
3.35
EV to EBIT
-17.90
EV to EBITDA
13.45
EV to Capital Employed
10.19
EV to Sales
1.71
PEG Ratio
1.70
Dividend Yield
NA
ROCE (Latest)
-56.95%
ROE (Latest)
15.83%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
114.20
99.70
14.54%
Operating Profit (PBDIT) excl Other Income
-236.50
-366.30
35.44%
Interest
2.60
0.70
271.43%
Exceptional Items
0.20
0.10
100.00%
Consolidate Net Profit
-259.30
-346.10
25.08%
Operating Profit Margin (Excl OI)
-2,256.60%
-3,966.70%
171.01%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 14.54% vs 34.01% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 25.08% vs 46.11% in Dec 2024
About Antengene Corp. Ltd. 
Antengene Corp. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






